Science Will WinTM
We believe science can cure every human disease. And we're going all in.
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
ALBERT BOURLA ON ENSURING EQUITABLE ACCESS TO COVID-19 VACCINES
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
THE ANTIGEN: #COVID19 PODCAST
VISIT OUR COVID-19 HUB
Latest News
Myovant Sciences and Pfizer Inc. today announced that the Phase 3 SPIRIT long-term extension study of the investigational once-daily relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5 mg) in women with endometriosis reported clinically meaningful reductions in dysmenorrhea (menstrual pain) and non-menstrual pelvic pain over one year (52 weeks) with minimal and stable bone mineral density loss.